Table 3.
The ranking of probability of different interventions was estimated by comparing the SUCRA.
| Treatment | SUCRA | Pr best | Mean rank |
|---|---|---|---|
| For IPSS | |||
| T | 11.2 | 0.0 | 5.4 |
| S25+T | 86.3 | 51.7 | 1.7 |
| T5+T | 71.0 | 25.0 | 2.5 |
| T20+T | 36.2 | 0.3 | 4.2 |
| T10+T | 18.9 | 0.0 | 5.1 |
| V10+T | 76.6 | 23.0 | 2.2 |
| For Qmax | |||
| T | 33.8 | 0.0 | 5.0 |
| S25+T | 80.7 | 7.5 | 2.2 |
| T5+T | 15.2 | 0.0 | 6.1 |
| T20+T | 42.7 | 0.0 | 4.4 |
| T10+T | 8.8 | 0.0 | 6.5 |
| V10+T | 70.9 | 1.1 | 2.7 |
| S4+T | 98.0 | 91.4 | 1.1 |
| For IIEF | |||
| T | 0.1 | 0.0 | 5.0 |
| S25+T | 99.9 | 99.6 | 1.0 |
| T20+T | 72.8 | 0.4 | 2.1 |
| T10+T | 35.0 | 0.0 | 3.6 |
| V10+T | 42.2 | 0.0 | 3.3 |
| The safety outcomes of treatment comparisons | |||
| T | 93.2 | 68.7 | 1.3 |
| S25+T | 63.7 | 4.8 | 2.8 |
| T5+T | 56.0 | 24.3 | 3.2 |
| T20+T | 40.0 | 0.0 | 4.0 |
| T10+T | 16.3 | 2.1 | 5.2 |
| V10+T | 30.7 | 0.1 | 4.5 |